State of globe: Neutrophil CD64: Is it a reliable biomarker for sepsis?
Main Authors: | Sajal Ajmani, Vikas Agarwal, Mohan Gurjar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Global Infectious Diseases |
Online Access: | http://www.jgid.org/article.asp?issn=0974-777X;year=2018;volume=10;issue=2;spage=33;epage=34;aulast=Ajmani |
Similar Items
-
The Utility of Neutrophil CD64 and Presepsin as Diagnostic, Prognostic, and Monitoring Biomarkers in Neonatal Sepsis
by: Heba E. Hashem, et al.
Published: (2020-01-01) -
NEUTROPHIL CD64 INDEX IN SEPSIS DIAGNOSIS AFTER CARDIAC SURGERY IN INFANTS
by: A. A. Krivoshapkina, et al.
Published: (2014-05-01) -
Diagnostic utility of neutrophil CD64 as a marker for early-onset sepsis in preterm neonates.
by: Jikun Du, et al.
Published: (2014-01-01) -
Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis
by: Shan Cong, et al.
Published: (2021-04-01) -
Valuable Role of Neutrophil CD64 and Highly Sensitive CRP Biomarkers for Diagnostic, Monitoring, and Prognostic Evaluations of Sepsis Patients in Neonatal ICUs
by: Heba E. Hashem, et al.
Published: (2020-01-01)